Tauroursodeoxycholic acid attenuates cisplatin-induced ototoxicity by inhibiting the accumulation and aggregation of unfolded or misfolded proteins in the endoplasmic reticulum-Reference-Cited by-同舟云学术

Tauroursodeoxycholic acid attenuates cisplatin-induced ototoxicity by inhibiting the accumulation and aggregation of unfolded or misfolded proteins in the endoplasmic reticulum

Published:2021-04 Issue: Volume:453 Page:152736
ISSN:0300-483X
Container-title:Toxicology
language:en
Short-container-title:Toxicology

Author:

Wen Yingying,Zong Shimin,Liu Tianyi,Du Peiyu^ORCID,Li Hao,Xiao Hongjun^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Toxicology

Reference48 articles.

1. Protein quality control in the endoplasmic reticulum;Adams;Protein J.,2019

2. Determination of glutathione disulfide levels in biological samples using thiol-disulfide exchanging agent, dithiothreitol;Ates;Biomed. Chromatogr.,2009

3. Structure-function analysis of the tertiary bile acid TUDCA for the resolution of endoplasmic reticulum stress in intestinal epithelial cells;Berger;Biochem. Biophys. Res. Commun.,2011

4. Ototoxicity monitoring in children treated with platinum chemotherapy;Brooks;Int. J. Audiol.,2018

5. Id1/NR2B receptor pathway regulates rat cochlear sensory epithelial cell survival after radiation;Chen;Audiol. Neurotol.,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Probucol-Ursodeoxycholic Acid Otic Formulations: Stability and In Vitro Assessments for Hearing Loss Treatment;Journal of Pharmaceutical Sciences;2024-08

2. Activating transcription factor 6 contributes to cisplatin‑induced ototoxicity via regulating the unfolded proteins response;Biomedicine & Pharmacotherapy;2024-08

3. Bile Acid Application in Cell-Targeting for Molecular Receptors in Relation to Hearing: A Comprehensive Review;Current Drug Targets;2024-02

4. Modulating the Unfolded Protein Response with ISRIB Mitigates Cisplatin Ototoxicity;2023-10-17

5. CRTAC1 enhances the chemosensitivity of non-small cell lung cancer to cisplatin by eliciting RyR-mediated calcium release and inhibiting Akt1 expression;Cell Death & Disease;2023-08-26